DIA465.06-0.42 -0.09%
SPY655.83+0.59 0.09%
QQQ584.98+0.67 0.11%

Earnings Scheduled For March 27, 2026

Benzinga·03/27/2026 11:11:10
Listen to the news

Companies Reporting Before The Bell

• Instil Bio (NASDAQ:TIL) is expected to report earnings for its fourth quarter.

• BioXcel Therapeutics (NASDAQ:BTAI) is projected to report quarterly loss at $0.52 per share on revenue of $142 thousand.

• Legence (NASDAQ:LGN) is expected to report quarterly earnings at $0.02 per share on revenue of $618.01 million.

• Werewolf Therapeutics (NASDAQ:HOWL) is likely to report quarterly loss at $0.34 per share on revenue of $600 thousand.

• Humacyte (NASDAQ:HUMA) is estimated to report quarterly loss at $0.13 per share on revenue of $1.44 million.

• Autolus Therapeutics (NASDAQ:AUTL) is projected to report quarterly loss at $0.38 per share on revenue of $23.24 million.

• SBC Medical Group Holding (NASDAQ:SBC) is likely to report quarterly earnings at $0.12 per share on revenue of $46.06 million.

• Yunji (NASDAQ:YJ) is likely to report earnings for its Fiscal Year 2025.

• Huize Holding (NASDAQ:HUIZ) is estimated to report earnings for its Fiscal Year 2025.

• 51 Talk Online Education (AMEX:COE) is likely to report earnings for its fourth quarter.

• Kopin (NASDAQ:KOPN) is projected to report quarterly loss at $0.01 per share on revenue of $11.65 million.

• LM Funding America (NASDAQ:LMFA) is expected to report quarterly loss at $0.45 per share on revenue of $2.80 million.

• TMC The Metals Co (NASDAQ:TMC) is projected to report earnings for its fourth quarter.

• Super League Enterprise (NASDAQ:SLE) is projected to report quarterly loss at $2.98 per share on revenue of $3.58 million.

Companies Reporting After The Bell

• Origin Materials (NASDAQ:ORGN) is likely to report earnings for its fourth quarter.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Contact Us

Contact Number :+852 3852 8500
Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hk
Online Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hk
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language

English

©2026 Webull Securities Limited. All rights reserved.